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Abstract
Background: The evaluation of quality of life in cancer patients is of 
interest to researchers due to its impact on health policies. The aim 
of this study was to assess the quality of life of patients with breast 
and gynecological cancer, undergoing chemotherapy. 
Methods and Findings: This was a quantitative, descriptive and 
longitudinal study, conducted in the Clinical Hospital of the Triangulo 
Mineiro Federal University. To assess the quality of life, the Portuguese 
brief version of the World Health Organization Quality of Life (WHO-
QOL-BREF) instrument was applied. The paired Student’s t-test was 
used for the analysis of the means of/ the scores of the domains. The 
study included 14 women. The lowest means were observed in the 
physical domain, 51.78±15.89 and 50.25±15.37, respectively before 
and after treatment. There was also a compromise of the psycholo-
gical and environment domains, however, the data analyzed did not 
show statistical significance. The main limitation of this study is the 
sample size.
Conclusion: Quality of life presents itself as an important factor for 
the measurement of results in clinical studies.
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Introduction
The diagnosis of cancer generally has a devastating effect on the life 
of the recipient. Fear of the mutilations and disfigurations that can 
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result from the treatment, as well as the fear of 
death and the many losses in the emotional, social 
and material spheres almost always occur [1].
An important aspect to consider is the history of 
the disease throughout time and culture, with its 
meanings and symbology. The history of the indivi-
dual with cancer is full of fear and shame, leading to 
an unconscious retreat to ancestral fears, filled with 
dread and expectations that resist the advances of 
science [2]. In this way, cancer is still a difficult secret 
to be shared, narrated and heard, even for women, 
who are culturally more encouraged to share, inte-
grate and socialize experiences [1], which probably 
compromises their quality of life.
The technological development of oncology has 
resulted in new treatments with great healing po-
tential. However, while survival has increased, bene-
fits related to quality of life have not been achieved 
[3].
Recently, the evaluation of the quality of life in 
patients with cancer has aroused the interest of re-
searchers. Under the influence of the change in the 
health paradigm of the social production of health, 
centered on the complex health-disease process, it 
is increasingly sought to unravel the perspective of 
acting on the course of the natural history of disea-
ses and health problems [4, 5].
Regarding the conceptual and methodological as-
pects of quality of life, the review of the literature 
emphasizes that they should be evaluated by the 
individual, unlike the initial tendency in which they 
were evaluated by an observer. The studies carried 
out in the health area present two approaches, one 
more generic and the other related to health. Stu-
dies based on the generic concept of quality of life 
present evaluations of healthy people of the popu-
lation, with the total exclusion of those with spe-
cific diseases. The investigations that depart from 
the concept related to health are associated with 
diseases or interventions in health [4].
The concept of quality of life, on which this study 
is based, is presented by the World Health Orga-
nization Quality of Life (WHOQOL) Group, which 
defines quality of life as “the individuals’ percep-
tion of their position in life in the context of the 
culture and value systems in which they live and in 
relation to their goals, expectations, standards and 
concerns” [6].
In Brazil, there has been increasing interest in the 
quality of life in the health field. There are count-
less publications that refer to data regarding the 
influence of external factors, diseases, temporary 
conditions such as surgeries and even cancer, affec-
ting the quality of life score.
Thus, the aim of this study was to evaluate the 
quality of life of patients with breast and gyneco-
logical cancer, according to the WHOQOL-BREF va-
lidated instrument, in the pre- and post-chemothe-
rapy moments.
Methods
This was a quantitative observational study, with a 
descriptive character and a prospective longitudinal 
design. The study was carried out at the Central 
Chemotherapy Unit of the Clinical Hospital of the 
Triangulo Mineiro Federal University (CQ/HC/UFTM), 
in the city of Uberaba/MG.
The study included 14 women, selected through 
the following inclusion criteria: aged 18 years or 
over diagnosed with breast or gynecological can-
cer by the Gynecological Oncology Service of the 
Gynecology and Obstetrics Department and that 
underwent chemotherapy, in the period from 
December 2012 to April 2013, at CQ/HC/UFTM. 
All the women who started chemotherapy du-
ring the defined period of data collection were 
included in the study, with no sample calculation 
being performed, thus constituting a convenience 
sample.
Considering the aggressiveness of the chemothe-
rapy treatment and that the quality of life of the 
women submitted to this treatment was the focus 
of the study, it was chosen to include all those 
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who performed the treatment during the deve-
lopment of the study, regardless of the primary 
onco-gynecological diagnosis and the other forms 
of oncological treatment that these women un-
derwent, before or after the chemotherapy, such 
as surgery, radiotherapy or hormone therapy.
The information needed to develop the study 
was obtained using the data collection instru-
ment proposed by the World Health Organization 
(WHO), the Portuguese abbreviated version of the 
World Health Organization Quality of Life (WHO-
QOL-BREF) assessment. This is a generic instrument 
composed of 26 questions, two being general is-
sues of quality of life and 24 representing each of 
the 24 facets that comprise the physical, psycholo-
gical, social relationships and environment doma-
ins [6, 7]. The questions of the instrument were 
answered in a private place, based on the last two 
weeks of life [6, 7], after the participants signed a 
consent form. The WHOQOL-BREF was applied at 
two moments, immediately before the first cycle 
of chemotherapy and after the third cycle. The re-
sults obtained were categorized on a Likert type 
scale, in which, the higher the score, the better 
the quality of life [8].
The data were stored in an Excel® spreadsheet 
and then imported into the Statistical Package 
for the Social Sciences(SPSS) version 20.0 statisti-
cal program. From the application of the validated 
WHOQOL-BREF instrument, the mean scores of the 
domains were analyzed using the paired Student’s 
t-test. The level of statistical significance for all in-
ferential procedures was 5%.
Approval of the Research Ethics Committee (CEP) 
of UFTM was obtained for the development of the 
study under authorization No. CEP/UFTM: 2304. 
The ethical aspects of Resolution 196/96 of the Na-
tional Health Council on research involving human 
subjects were followed, since the study precedes 
the publication of Resolution 466/12.
Results
The group of subjects (n=14) was composed mainly 
of women between 41 and 60 years of age (56.3%); 
with a fixed partner (62.5%), Catholic (62.5%), with 
individual monthly income of up to one minimum 
wage (62.5%). It is interesting to observe the pre-
valence in the sample of women (31.3%) with low 
levels of education (1 to 4 years of schooling) and 
with average levels of education (9 to 11 years) - 
31.3%, which compose a heterogeneous group in 
relation to the degree of understanding of the in-
formation provided.
Regarding the clinical aspects, five (31.3%) of 
the women were diagnosed with breast cancer and 
another five (31.3%) with cervical cancer. The re-
maining patients were diagnosed with ovarian car-
cinoma, hydatidiform mole, vulvar neoplasm, and 
endometrial carcinoma.
The vast majority (75%) of the women had un-
dergone some kind of surgery before starting che-
motherapy; half of them had received complemen-
tary radiotherapy and 62.5% had used platinum 
derivatives as a chemotherapy protocol.
The results obtained from the assessment of the 
quality of life of the women with breast and gyne-
cological cancer prior to beginning the proposed 
chemotherapy treatment and the evaluation of the 
domains of quality of life after the chemotherapy 
are presented in Table 1. The Cronbach’s alpha value 
ranged from 0 to 1, with the best levels of internal 
consistency being those closest to 1. It should be 
noted that the social domain has only three items, 
which implies impairment in the use of Cronbach’s 
alpha for internal validity, since the recommended 
for this type of analysis is the presence of at least 
four items [9].
In the pre-chemotherapy moment, the analysis 
of the physical domain of the WHOQOL-BREF pre-
sented the lowest mean score, 51.78±15.89. Post-
chemotherapy, the same domain continued to pre-
sent the lowest mean score, 50.25±15.37. It can 
be seen that there was a small reduction in the 
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Table 1.  Evaluation of the quality of life of women with breast and gynecological cancer according to 
the WHOQOL-BREF domains at the pre-chemotherapy and post-chemotherapy moments (n=14). 
Uberaba (MG), 2013.
Domains Minimum Mean Median Maximum Standard Deviation Cronbach’s alpha
Pre-Chemotherapy
Physical 28.57 51.78 57.14 67.86 15.89 0.62
Psychological 37.50 66.96 66.66 87.50 16.21 0.73
Social 50.00 71.42 70.83 91.67 14.13 -
Environment 40.63 64.50 62.50 87.50 12.59 0.73
Post-Chemotherapy
Physical 21.43 50.25 51.78 71.43 15.37 0.71
Psychological 20.83 60.41 64.58 87.50 20.65 0.84
Social 33.33 72.61 75.00 100.00 17.73 0.31
Environment 31.25 58.92 62.50 75.00 14.02 0.74
Domains Paired Student’s t P-value
Pre-Chemo X Post-Chemo
Physical 0.31 0.763
Psychological 1.88 0.083
Social -0.46 0.655
Environment 2.00 0.066
mean score between the pre-chemotherapy and 
post-chemotherapy moments, however, without 
statistical significance (p=0.763).
The psychological domain of the WHOQOL-BREF 
at the pre-chemotherapy moment presented a hig-
her mean score of 66.96±16.21 compared to the 
mean score at the post-chemotherapy moment of 
60.41±20.65, however, with no statistically signifi-
cant difference (p=0.083).
Regarding the social domain of the WHOQOL-
BREF, a mean score of 71.42±14.13 was observed 
at the pre-chemotherapy moment, while at the 
post-chemotherapy moment this score was slightly 
higher (72.61±17.73), however, without statistical 
significance (p=0.655).
At the pre-chemotherapy moment, a mean sco-
re of 64.50±16.21 was observed in the WHOQOL-
BREF environment domain, with a reduction post-
chemotherapy to a mean score of 58.92±14.02, 
however, also without statistical significance 
(p=0.066).
Discussion
The therapeutic approach of patients with breast 
and gynecological cancer involves a high degree 
of concern regarding their survival. Thus, the as-
sessment of the quality of life should be considered 
during all stages of diagnosis and treatment of the 
disease, since various cancer related symptoms and 
complications and their treatment can significantly 
affect the domains of quality of life involving the 
physical, psychological, social and environmental 
well-being.
Analyzing the physical domain, a study of 50 
patients with gynecological cancer submitted to 
InternatIonal archIves of MedIcIne 
sectIon: obstetrIcs & GynecoloGy
ISSN: 1755-7682
2017
Vol. 10 No. 233
doi: 10.3823/2503
© Under License of Creative Commons Attribution 3.0 License 5
chemotherapy concluded that this domain of the 
WHOQOL-BREF was the most compromised, with 
a mean score of 56, probably due to the toxicity of 
the chemotherapeutic drugs used in the treatment 
related to the cellular non-specificity. The main side 
effects observed were nausea, vomiting, mucositis, 
pain, fatigue and weakness that made it difficult for 
these patients to perform the activities of daily li-
ving, consequently impairing their quality of life [10].
In a study carried out in Antioquia, Colombia 
(2010), with 220 women with breast cancer who 
underwent chemotherapy, the mean score of the 
physical domain of the WHOQOL-BREF was 63, 
with this domain being the most affected in the 
study [11]. It should be noted that the mean score 
of the physical domain was higher than that found 
in the present study, suggesting that this difference 
stems from the cultural and economic differences 
existing between the two countries, as well as the 
tumor type and the consequences of the treatment. 
In this study the quality of life of patients was cha-
racterized as intermediate.
The ability to work, whether at home or outsi-
de, is diminished, with a high number of people 
taking sick leave or leaving their work during the 
treatment period, leading to personal dissatisfac-
tion. Women with breast cancer experience alte-
rations in their functional capacity, which impairs 
the performance of their daily activities and their 
social participation, leading to the impairment of 
the quality of life [12].
Weakness, tiredness and fatigue were cited by 
several authors as factors that influence the quality 
of life of the patients, corroborating the data found 
in this study [13, 14, 15].
Thus, it can be inferred that the quality of life of 
the patients interviewed in the present study, with 
respect to their physical aspects, was influenced 
from the moment the disease was diagnosed un-
til the final outcome. The chemotherapy treatment 
explains the reduction in the mean quality of life 
scores of these women, who were already living 
with their quality of life compromised due to the 
diagnosis. It is important to increase the sample size 
in order to increase the statistical power of the test 
used.
The questions related to the psychological do-
main deal with positive feelings; thinking and lear-
ning; self esteem; body image; negative feelings; 
and spirituality [9]. Women idealize and elaborate 
a body image surrounded by physiological, psycho-
logical and social aspects that affect the emotions, 
thoughts and the way of relating with other people, 
significantly influencing their quality of life, a fact 
observed in the present study.
Alopecia is described by cancer patients as the 
most devastating of the side effects of the che-
motherapy treatment. They say that this symptom 
becomes frightening in that the hair is a fundamen-
tal part of their physical appearance and its loss 
affects the self-image and impairs their social rela-
tionships [16].
A study evaluated the self-esteem of 37 women 
who had undergone breast cancer surgery at least 
one year previously. It was observed that 54.10% of 
the women had high self-esteem. This differed from 
what has been shown in other studies, with the 
authors justifying the finding based on the mean 
age of the women (56.11 years). According to the 
study, self-esteem tends to increase with aging, 
being related to the fact that 55% of them were 
in a stable relationship and 20% had performed 
breast reconstruction [17].
Another important aspect to be considered in the 
psychological domain is spirituality, understood as a 
set of emotions and convictions of a non-material 
nature, referring to questions such as the signifi-
cance and meaning of life. This can represent an 
important source of comfort and support for many 
people during the period of suffering, bringing 
them serenity to face the adversities of the disea-
se [18]. In this sense, one study observed that the 
women with cancer who participated in the study 
mentioned, in addition to adherence to treatment 
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and family support, the need for other forms of 
coping with the disease, with religion representing 
an important supportive role. Faced with cancer, the 
women generally became more sensitive, in need of 
protection, and relied on their religious and spiritual 
beliefs [19].
The questions related to the social domain relate 
to personal relationships, support and sexual activity 
[9]. Interestingly, among the domains of the WHO-
QOL-BREF in the present study, the social domain 
was the only one in which the mean scores showed 
an increase after the chemotherapy, even though 
small and without statistical significance, in relation 
to the mean scores before the women started the 
proposed chemotherapeutic treatment.
One study discussed the impact of breast surgery 
on female sexuality and found a close relationship 
between physical discomfort and difficulties in resu-
ming sexual activity after breast removal surgery. It 
also highlighted a high susceptibility of women with 
breast cancer to physical and psychosocial stressors, 
contributing to a lowering in the quality of life of 
these women [20].
It is important to consider that the chemothe-
rapeutic treatment for the cancer patient is a fac-
tor of exclusion from the social life previously ex-
perienced, since there is an increase in insecurity, 
considering that society determines the behavior, 
appearance and productivity expected. Illness and 
treatment can influence individual experiences and, 
through interpersonal relationships, patients can ex-
press and reorganize their thoughts and emotions. 
Patients make adaptations in their lives and seek 
to maintain their social relationships together with 
their families [16].
Regarding the environment domain, the WHO-
QOL-BREF questions address physical security, the 
home environment, financial resources, health care, 
information, recreation and leisure, physical environ-
ment and transportation [9].
A study performed with 454 women with breast 
cancer, regarding the reasons for not attending 
the health service for rehabilitation or continuity 
of the treatment, observed that 101 (22.2%) of 
them mentioned their occupation in the home as 
a predisposing factor, while 87 (19.2%) mentioned 
the difficulty in getting to the service, including 
the means of transportation and distance from 
the place [21]. Thus, it can be inferred that wo-
men, even in treatment, continue to be directly 
involved in the activities of the home and in family 
relationships, being responsible for caring for the 
family, which justifies the occupation and genera-
tes lack of time and family problems. In addition, 
the difficulty of transportation, distance and other 
health problems presented contribute to their lack 
of availability and willingness to attend the health 
service.
In evaluating leisure, one study highlighted that 
this is an important element in coping with cancer 
and that the women interviewed reported that, fa-
ced with the uncertainty of the future, they found, 
in an activity that they considered pleasurable, the 
opportunity to enjoy life while they were allowed 
to live [19]. Among women with breast cancer, 
leisure was highlighted as an element of great 
importance, with repercussion in the life, acting 
as a powerful therapeutic resource. For them, lei-
sure was a way to seek the cure of the disea-
se, because, when distracted, the mind occupies 
itself pleasantly, moving away from the persistent 
and negative thoughts about the disease and its 
treatment [22].
Another study highlighted worse evaluations in 
the quality of life of women who survived breast 
cancer when compared to healthy women [23]. The 
domains in which there were worse evaluations 
were the physical, psychological and environment, 
as well as in the general quality of life [23].
An integrative review on the quality of life of 
cancer patients, carried out with Latin American 
studies, highlighted that there are still gaps in the 
knowledge in this area [24]. In spite of the limita-
tions of this study, mainly related to the number 
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of participants, which did not allow for a deeper 
statistical analysis, this study combines information, 
allowing a better understanding of the subject.
Conclusion
The quality of life evaluation, before and after the 
chemotherapeutic treatment of women with breast 
and gynecological cancer, in this study, showed that 
the lowest means were in the physical domain, be-
fore and after the treatment. There was also a sig-
nificant impairment of the psychological and envi-
ronment domains, however, the data analyzed were 
not statistically significant. This study, therefore, 
presents the low number of subjects as a limitation. 
However, the importance of studies of this nature 
that identify the influence of psychological disorders 
on the quality of life of women with breast and 
gynecological cancer who undergo chemotherapy 
treatment can be observed.
Quality of life has been presented as an impor-
tant factor for the measurement of results in clini-
cal studies. Therefore, it is necessary to carry out 
evaluations at the beginning of the treatment and 
after the administration of the chemotherapy, in or-
der to provide follow-up results, aiming for efficient 
and effective performance of the health team in 
improving the aspects of quality of life of the pa-
tients with cancer undergoing chemotherapy. This 
approach should be performed in a careful and 
insightful way in order to detect relevant changes 
in the life of each patient, taking into account the 
fact that the data found may affect the results and 
outcomes of the proposed therapies.
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